Skip to main content

Featured

Daily Markets Update: Oil Rattles TSX Ahead of BoC Hike Week | Oct 26

  Canadian Money Brief • Daily Markets Update Monday, October 26, 2026 • Covers Friday’s North American and European closes plus Monday’s Asian session Oil took over from AI as the market’s main worry on Friday. Crude jumped above US$100 on fresh attacks on Saudi Arabia, the S&P/TSX Composite finished the week lower, and Wall Street logged a second straight weekly loss for the S&P 500. Monday brought a small reprieve: oil slipped after no weekend escalation in the Iran war, and most Asian and European markets steadied — just ahead of a week stacked with central bank decisions, including the Bank of Canada on Wednesday. The 30-second version TSX: 35,788.18 , down 185.27 points (−0.52%) Friday; −1.07% on the week. Wall Street: Dow −1.2%, S&P 500 −0.5%, Nasdaq −0.2%. Oil: WTI settled at US$103.27 ; Brent at US$116.72 . Loonie: 71.46¢ US , a five-week high. Bank of Canada: markets price roughly an 80% chance of a hike to 2.50% on Wednesday. Canada: TSX Ends the Week in the...

article

Provincial Directive Curbs AHS Authority Over Private Surgical Contract Negotiations

 


In a significant policy shift, Alberta Health Minister Adriana LaGrange has stripped Alberta Health Services (AHS) of its authority to negotiate contracts with private surgical facilities. According to a government directive obtained by media, the change came after internal concerns—raised by the agency’s then-chief executive—over rising contract costs.

Documents, including a letter from former AHS CEO Athana Mentzelopoulos’s lawyer, allege that senior government officials—even involving Premier Danielle Smith’s former chief of staff—intervened in AHS’s procurement process to favor private companies. This interference reportedly undermined AHS’s established negotiation powers and raised serious questions about transparency in the province’s health system. 

A separate report in a Morning Update from Unpublished Newswire reiterated the move, noting that the directive is part of broader reforms aimed at reducing costs by leveraging competitive pricing in surgical services.  Meanwhile, a CityNews investigation has added context to the controversy, citing denials by private surgical providers who label the allegations of sweetheart deals as “false and baseless.” 

Critics and opposition leaders are calling for further inquiry into the decision-making process behind these changes, arguing that the shift could signal a move toward greater privatization of public health services. In contrast, government representatives insist that the directive is intended solely to improve efficiency and ensure more competitive pricing for publicly funded operations.

Comments